NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Sample GSM545742 Query DataSets for GSM545742
Status Public on Dec 31, 2011
Title C032_Control_M_76
Sample type RNA
 
Source name Brain BA22 post-mortem control
Organism Homo sapiens
Characteristics gender: Male
age: 76
post-mortem delay: 6h
ph: 6
disease state: control
tissue: superior temporal cortex (Brodmann Area 22, BA22)
Extracted molecule total RNA
Extraction protocol Total RNA was extracted from frozen BA22 using a Polytron type homogenizer (YellowLine DI 25 Basic) and TriZol reagent (Invitrogen, Paisley, UK) in a ratio of 1 ml of TriZol to 20 mg of tissue. RNA was further purified using RNeasy mini-columns (Qiagen, Valencia, CA, USA) including on-column DNAse-1 step and elution in water. Although pH was analysed in brain lysates using a pH meter, this was not considered to be rigorous enough to exclude or include samples and instead the RNA integrity number (RIN) was used to assess the quality of the RNA as the primary inclusion criterion. The quantity of extracted RNA was determined by spectrophotometry and quality was assessed using an Agilent 2100 Bioanalyzer (South Plainfield, NJ, USA) to determine the RIN. Based on the RIN, samples were classified into three quality groups—pass (RIN >7.0); borderline (RIN 6.0–7.0); fail (RIN<6.0). Following classification, there were 41 pass (RIN range of samples 7.0–9.0: average=7.7), 16 borderline (RIN range of samples 6.0–6.9; average=6.4) and 5 fail samples. Samples in the fail category were excluded from the study, and the remaining samples were randomized into four batches, containing an equal number of schizophrenic/control and male/female samples, for target generation and hybridization.
Label biotin
Label protocol For each batch, 10ug total RNA was processed to Biotin-labeled cRNA and hybridized to HG-U133_Plus_2.0 GeneChips in accordance with the Affymetrix protocol (Affymetrix, Santa Clara, CA, USA,).
 
Hybridization protocol For each batch, 10ug total RNA was processed to Biotin-labeled cRNA and hybridized to HG-U133_Plus_2.0 GeneChips in accordance with the Affymetrix protocol (Affymetrix, Santa Clara, CA, USA,).
Scan protocol Arrays were scanned on a GeneChip Scanner 3000 and fluorescence intensity for each feature of the array was obtained by using GeneChip Operating Software (Affymetrix).
Description n/a
Data processing The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method. The trimmed mean target intensity of each array was arbitrarily set to 150.
 
Submission date May 20, 2010
Last update date Dec 31, 2011
Contact name Julie Huxley-Jones
E-mail(s) [email protected]
Phone 01438 768416
Organization name GlaxoSmithKline Pharmaceuticals
Department Computational Biology
Street address Gunnels Wood Road
City Stevenage
State/province Hertfordshire
ZIP/Postal code SG1 2NY
Country United Kingdom
 
Platform ID GPL570
Series (1)
GSE21935 Comparison of post-mortem tissue from Brodman Brain BA22 region between schizophrenic and control patients

Data table header descriptions
ID_REF
VALUE MAS5.0 signal intensity

Data table
ID_REF VALUE
AFFX-BioB-5_at 256.7828979
AFFX-BioB-M_at 373.2400208
AFFX-BioB-3_at 210.3384705
AFFX-BioC-5_at 577.5950928
AFFX-BioC-3_at 534.7028809
AFFX-BioDn-5_at 879.1108398
AFFX-BioDn-3_at 3084.484131
AFFX-CreX-5_at 6374.386719
AFFX-CreX-3_at 7663.364746
AFFX-DapX-5_at 14.48931694
AFFX-DapX-M_at 7.035664082
AFFX-DapX-3_at -7.800614834
AFFX-LysX-5_at -1.496486783
AFFX-LysX-M_at 0.277484685
AFFX-LysX-3_at 6.843986034
AFFX-PheX-5_at -7.990244865
AFFX-PheX-M_at -12.36998367
AFFX-PheX-3_at 4.645025253
AFFX-ThrX-5_at -5.022223949
AFFX-ThrX-M_at -3.849349737

Total number of rows: 54675

Table truncated, full table size 1223 Kbytes.




Supplementary file Size Download File type/resource
GSM545742_jrs_U133p2_DB2_55_C032_R97549.CEL.gz 4.9 Mb (ftp)(http) CEL
Processed data included within Sample table

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap